← Open Payments lookup

AMANDA BUSCHBACH: Open Payments

NPI 1255738332 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$311 in 14 payments from 9 companies in 2025. Trend: 2023 $400 · 2024 $308 · 2025 $311

Food & beverage: $311
CompanyPaymentsAmount
Merck Sharp & Dohme LLC3$69
United Therapeutics Corporation2$64
GENZYME CORPORATION2$43
Boehringer Ingelheim Pharmaceuticals, Inc.2$38
Calliditas Therapeutics US Inc.1$25
Regeneron Healthcare Solutions, Inc.1$24
ABBVIE INC.1$17
Mallinckrodt Hospital Products Inc.1$16
Philips North America LLC1$15

Products named: DUPIXENT, ZERBAXA, Tyvaso, Remodulin, WINREVAIR, TARPEYO, JASCAYD, OFEV.

Industry payments across AL — which companies pay providers there.